SCHEMBL7316250

SCHEMBL7316250

COc1ccccc1C1(O)c2ccccc2-c2ccccc21

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.56
PDK2 Q15119 5/20 0.50
SIGMAR1 Q99720 1/20 0.50
CA1 P00915 3/20 0.46
CA2 P00918 3/20 0.46
CA7 P43166 2/20 0.46
CA9 Q16790 2/20 0.46
CA12 O43570 1/20 0.46
CA4 P22748 1/20 0.46
CA14 Q9ULX7 1/20 0.46
CHRM2 P08172 1/20 0.44
CHRM4 P08173 1/20 0.44
CHRM5 P08912 1/20 0.44
CHRM1 P11229 1/20 0.44
CHRM3 P20309 1/20 0.44
TP53 P04637 1/20 0.43
TSHR P16473 1/20 0.43
SCN9A Q15858 1/20 0.43
APP P05067 1/20 0.42
OPRM1 P35372 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21880258 0.84 PDK2 (0.54) KMT2APDK2SIGMAR1
SCHEMBL14191206 0.79 CA1 (0.50) KMT2APDK2SIGMAR1CA1CA2
SCHEMBL18858207 0.77 PDK2 (0.46) KMT2APDK2TSHRALDH1A1HPGD
SCHEMBL12802716 0.77 KMT2A (0.49) KMT2APDK2SIGMAR1CA1CA2
SCHEMBL7314812 0.77 SCN9A (0.48) KMT2APDK2CA1CA2CA7
SCHEMBL11041928 0.74 KMT2A (0.71) KMT2APDK2SIGMAR1CA1CA2
SCHEMBL30683762 0.74 KMT2A (0.50) KMT2APDK2SIGMAR1CA1CA2
SCHEMBL7315127 0.73 PDK2 (0.51) KMT2APDK2CA1CA2CA7
SCHEMBL10490946 0.73 KMT2A (0.53) KMT2APDK2SIGMAR1CA1CA2
SCHEMBL7313945 0.72 PDK2 (0.46) PDK2CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6162824-A NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS ALLELIX NEUROSCIENCE INC. 2000-12-19 US disclosed
WO-1999041227-A1 TRICYCLIC COMPOUNDS AS GLYCINE TRANSPORT INHIBITORS ALLELIX NEUROSCIENCE, INC. (US) 1999-08-19 WO disclosed